Molecular pathogenesis of oral submucous fibrosis--a collagen metabolic disorder.

Oral submucous fibrosis (OSF) is a chronic debilitating disease and a premalignant condition of the oral cavity. It is characterized by a generalized submucosal fibrosis. The pathogenesis of the disease is not well established. Epidemiological evidences strongly indicate the association of the betel quid (BQ) habit and OSF. Various findings indicate the disease to be a consequence of disturbances in the homeostatic equilibrium between synthesis and degradation of extracellular matrix (ECM), wherein collagen forms a major component, thus can be considered as a collagen-metabolic disorder. Transforming growth factor-beta (TGF-beta) is a potent stimulator of production and deposition of the ECM. The objectives of this review are to highlight the molecular events involved in the overproduction of insoluble collagen and decreased degradation of collagen occurring via exposure to BQ and stimulation of the TGF-beta pathway, and elucidate the cell signaling that is involved in the etiopathogenesis of the disease process.

[1]  I A Razak,et al.  A national epidemiological survey of oral mucosal lesions in Malaysia. , 1997, Community dentistry and oral epidemiology.

[2]  H. Kagan,et al.  Reaction pathway of bovine aortic lysyl oxidase. , 1986, The Journal of biological chemistry.

[3]  T. Elattar,et al.  Cancer and the prostaglandins: a mini review on cancer research. , 1985, Journal of oral pathology.

[4]  M. Akagawa,et al.  Amine oxidase‐like activity of polyphenols , 2001 .

[5]  K. Danø,et al.  Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors. , 1990, The Journal of biological chemistry.

[6]  T. Wong,et al.  Modulation of lysyl oxidase by dietary copper in rats. , 1996, The Journal of nutrition.

[7]  T. Ramasami,et al.  Investigations on geometrical features in induced ordering of collagen by small molecules , 2003 .

[8]  D. Prockop,et al.  Type I procollagen N-proteinase from chick embryo tendons. Purification of a new 500-kDa form of the enzyme and identification of the catalytically active polypeptides. , 1989, The Journal of biological chemistry.

[9]  S. J. Chen,et al.  Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: involvement of Smad 3. , 1999, The Journal of investigative dermatology.

[10]  H. Kagan,et al.  Lysyl oxidase: properties, regulation and multiple functions in biology. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[11]  P. Gupta,et al.  Malignant transformation rate in oral submucous fibrosis over a 17-year period. , 1985, Community dentistry and oral epidemiology.

[12]  P. Gupta,et al.  Oral submucous fibrosis as a precancerous condition. , 1984, Scandinavian journal of dental research.

[13]  W. Border,et al.  Transforming Growth Factor β in Tissue Fibrosis , 1994 .

[14]  D J Prockop,et al.  Collagens: molecular biology, diseases, and potentials for therapy. , 1995, Annual review of biochemistry.

[15]  S. Kunkel,et al.  Novel roles for chemokines and fibroblasts in interstitial fibrosis. , 1998, Kidney international.

[16]  P. Andreasen,et al.  The plasminogen activation system in tumor growth, invasion, and metastasis , 2000, Cellular and Molecular Life Sciences CMLS.

[17]  D. Gomez,et al.  Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. , 1997, European journal of cell biology.

[18]  D. Greenspan,et al.  Transforming Growth Factor-β Regulation of Bone Morphogenetic Protein-1/Procollagen C-proteinase and Related Proteins in Fibrogenic Cells and Keratinocytes* , 1997, The Journal of Biological Chemistry.

[19]  P. Trackman,et al.  Regulation of lysyl oxidase, collagen, and connective tissue growth factor by TGF-beta1 and detection in human gingiva. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[20]  T. Axéll,et al.  Oral mucosal lesions associated with betel quid, areca nut and tobacco chewing habits: consensus from a workshop held in Kuala Lumpur, Malaysia, November 25-27, 1996. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[21]  W. Stetler-Stevenson,et al.  Metalloproteinase Activity Secreted by Fibrogenic Cells in the Processing of Prolysyl Oxidase , 1996, The Journal of Biological Chemistry.

[22]  Chien-Jen Chen,et al.  Interaction of collagen-related genes and susceptibility to betel quid-induced oral submucous fibrosis. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[23]  G. Cetta,et al.  Protective effect of flavonoids on the collagen of lathyritic rats , 1971, Experientia.

[24]  C. Keen,et al.  Incorporation of copper into lysyl oxidase. , 1997, The Biochemical journal.

[25]  F. Verrecchia,et al.  Identification of Novel TGF-β/Smad Gene Targets in Dermal Fibroblasts using a Combined cDNA Microarray/Promoter Transactivation Approach* , 2001, The Journal of Biological Chemistry.

[26]  T. Kupper Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations. , 1990, The Journal of clinical investigation.

[27]  Shun-Fa Yang,et al.  The upregulation of type I plasminogen activator inhibitor in oral submucous fibrosis. , 2003, Oral oncology.

[28]  P. Gupta,et al.  A case-control study of oral submucous fibrosis with special reference to the etiologic role of areca nut. , 1990, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[29]  S. Meghji,et al.  Oral submucous fibrosis patients have altered levels of cytokine production. , 2000, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[30]  L. Kohn,et al.  Procollagen peptidase: an enzyme excising the coordination peptides of procollagen. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Kwan Hw A statistical study on oral carcinomas in Taiwan with emphasis on the relationship with betel nut chewing: a preliminary report. , 1976 .

[32]  R. Adar,et al.  Type I procollagen C-proteinase from mouse fibroblasts. Purification and demonstration of a 55-kDa enhancer glycoprotein. , 1989, European journal of biochemistry.

[33]  A. Ghahary,et al.  Enhanced expression of mRNA for transforming growth factor-beta, type I and type III procollagen in human post-burn hypertrophic scar tissues. , 1993, Journal of Laboratory and Clinical Medicine.

[34]  M. Chou,et al.  The up-regulation of cyclooxygenase-2 expression in human buccal mucosal fibroblasts by arecoline: a possible role in the pathogenesis of oral submucous fibrosis. , 2003, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[35]  B. Nusgens,et al.  Procollagen type III N-terminal endopeptidase in fibroblast culture. , 1980, The Biochemical journal.

[36]  M. Kuo,et al.  High incidence of autoantibodies in Taiwanese patients with oral submucous fibrosis. , 2002, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[37]  J. J. Pindborg,et al.  Oral submucous fibrosis. , 1966, Oral surgery, oral medicine, and oral pathology.

[38]  R. Rajendran,et al.  An alternative pathogenetic pathway for oral submucous fibrosis (OSMF). , 1989, Medical hypotheses.

[39]  L. Chiang,et al.  Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis. , 2003, Oral oncology.

[40]  J. Klinman,et al.  The Catalytic Function of Bovine Lysyl Oxidase in the Absence of Copper* , 2001, The Journal of Biological Chemistry.

[41]  W. Harvey,et al.  Oral submucous fibrosis: its pathogenesis and management , 1986, British Dental Journal.

[42]  A. Eisen,et al.  Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Roberts,et al.  Smad-dependent Transcriptional Activation of Human Type VII Collagen Gene (COL7A1) Promoter by Transforming Growth Factor-β* , 1998, The Journal of Biological Chemistry.

[44]  H A Seedat,et al.  Betel-nut chewing and submucous fibrosis in Durban. , 1988, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[45]  Shun-Fa Yang,et al.  Increased tissue inhibitor of metalloproteinase-1 expression and inhibition of gelatinase A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis. , 2002, Oral oncology.

[46]  D. M. Walker,et al.  Oral submucous fibrosis. A review. , 1996, Australian dental journal.

[47]  W. Harvey,et al.  Stimulation of human buccal mucosa fibroblasts in vitro by betel-nut alkaloids. , 1986, Archives of oral biology.

[48]  V. M. Phillips,et al.  Collagen in submucous fibrosis: an electron-microscopic study. , 1990, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[49]  N. Oku,et al.  Inhibitory effect of green tea polyphenols on membrane-type 1 matrix metalloproteinase, MT1-MMP. , 2003, Biological & pharmaceutical bulletin.

[50]  T. Peters,et al.  Raised tissue copper levels in oral submucous fibrosis. , 2000, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[51]  N. Johnson,et al.  Copper stimulates human oral fibroblasts in vitro: a role in the pathogenesis of oral submucous fibrosis. , 2001, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[52]  Y. Ho,et al.  Areca nut extract up-regulates prostaglandin production, cyclooxygenase-2 mRNA and protein expression of human oral keratinocytes. , 2000, Carcinogenesis.

[53]  D. Greenspan,et al.  Bone Morphogenetic Protein-1: The Type I Procollagen C-Proteinase , 1996, Science.

[54]  I. Goldberg,et al.  Complex roles of tissue inhibitors of metalloproteinases in cancer , 2002, Oncogene.

[55]  B. Klosterhalfen,et al.  Modulation of Pro- and Antifibrinolytic Properties of Human Peritoneal Mesothelial Cells by Transforming Growth Factor β1 (TGF- β1), Tumor Necrosis Factor α (TNF-α) and Interleukin β1 (IL-1β) , 1998, Thrombosis and Haemostasis.

[56]  L. Liotta,et al.  Metalloproteinases and malignant conversion: does correlation imply causality? , 1989, Journal of the National Cancer Institute.

[57]  R. DiSilvestro,et al.  Evaluation of (+)-catechin action on lysyl oxidase activity in aortic tissue. , 1983, Biochemical pharmacology.

[58]  T. Takala,et al.  Pre- and Post-translational Regulation of Lysyl Oxidase by Transforming Growth Factor-β1 in Osteoblastic MC3T3-E1 Cells (*) , 1995, The Journal of Biological Chemistry.

[59]  M. Djordjevic,et al.  Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. , 1994, Journal of toxicology and environmental health.

[60]  W. Harvey,et al.  The aetiology of oral submucous fibrosis: the stimulation of collagen synthesis by extracts of areca nut. , 1981, International journal of oral surgery.